Avidity Biosciences Inc. (RNA) Receives IND Clearance from FDA to Proceed with the Phase 1/2 MARINA™ Trial of AOC 1001 in Adults with Myotonic Dystrophy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. IONS
4. ROIV
5. AAPL
6. ACN
7. AZN
8. ORCL
9. HOOD
10. QCOM

Go back to Avidity Biosciences Inc. (RNA) Receives IND Clearance from FDA to Proceed with the Phase 1/2 MARINA™ Trial of AOC 1001 in Adults with Myotonic Dystrophy
PROSENSA HOLD (NASDAQ: RNA) Delayed: 11.27 -2.92 (20.58%)
Previous Close $14.19    52 Week High $22.80 
Open $14.08    52 Week Low $4.12 
Day High $14.19    P/E N/A 
Day Low $11.13    EPS $0.00 
Volume 700,258